Company intelligence / Profile preview

Zuellig Pharma

Ownership: Private
Employees: ~12000
Development stage: Other

Overview

Zuellig Pharma provides end-to-end healthcare solutions in Asia including pharmaceutical and medical device distribution, commercialization support for global pharma/biotech companies (e.g., Moderna COVID vaccine), clinical trial logistics, patient care programs and digital health solutions across 17 markets with over 12,000 employees serving more than 350,000 healthcare facilities.

Modalities: Small moleculeBiologic (including mRNA-based drugs)Medical devices
Industry: Drug Discovery Services

Partnerships

Moderna Inc.Karo Healthcare

Beyond the preview

Go deeper on Zuellig Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zuellig Pharma.

Explore the full profile